Collaborating with the FDA on developing treatments for Inherited Retinal Diseases.
10 June 2023
Last June 8th, our co-founder Pr. Dr. Carel Hoyng attended to an important meeting with…
Rob Collin gave a talk during the DCRT (Dutch center for RNA therapeutics) session at the 2nd Dutch Antisense Therapeutics Symposium (DATS) (1st-2nd June).
5 June 2023
The past 1st and 2nd of June, the second Dutch Antisense Therapeutics Symposium (DATS) took…
Astherna is introduced to Minister Kuipers
12 May 2023
Earlier on 10th May, Rob had the honour of presenting our work to the Minister…
Astherna is growing! Three new colleagues joined to our team!
4 May 2023
We are excited! Three new members have joined to Astherna team! Berno Maaswinkel (CEO), Erwin…
Advanced imaging of the retina with ‘adaptive optics’
23 December 2022
They now have a novel 'adaptive optics' imaging device at the Department of Ophthalmology of…
Astherna to present at the HIHR pitch event November 16th
14 October 2022
Astherna has been nominated to give a pitch at the HIHR event! This eleventh edition…